Stocksigma LogoStocksigma Logo

Sagility Reports Strong Q2 FY27 Financial Growth and Acquires Chirok Health

Sagility delivered solid Q2 FY27 performance with revenue growing 22.5% YoY (12.2% CC) to ₹20,321M ($212.6M)

Sagility Reports Strong Q2 FY27 Financial Growth and Acquires Chirok Health

Sagility Ltd · Investor Presentation · 22 Oct 2026, 11:58 pm

Sagility Reports Strong Q2 FY27 Financial Growth and Acquires Chirok Health Sagility delivered solid Q2 FY27 performance with revenue growing 22.5% YoY (12.2% CC) to ₹20,321M ($212.6M). Adjusted EBITDA increased 23.0% YoY to ₹5,353M, expanding margins to 26.3%, while Adjusted PAT rose 8.1% YoY to ₹3,254M. The company secured $40.2M in ACV and announced an interim dividend of ₹0.15 per share. Total debt is on track to be fully repaid in FY27. Additionally, Sagility acquired Chirok Health for $20M upfront plus up to $12.35M contingent consideration to boost Provider segment RCM and CDI capabilities.

Original exchange filing (PDF)

More announcements from Sagility Ltd

All Sagility Ltd announcements